#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Restless legs syndrome Acute on chronic liver failure Nasopharyngeal cancer Thrombocytosis Gastric cancer Non-renal cell carcinoma of kidney Immunodeficiency congenital Pituitary-dependent Cushing's syndrome Chronic lymphocytic leukaemia refractory Congenital myopathy Acquired ATTR amyloidosis Deafness neurosensory Biliary cancer metastatic Rosai-Dorfman syndrome Pseudomyxoma peritonei More trials…

    Learn about Rare Diseases

    Medulloblastoma recurrent – Treatment Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information Chondrosarcoma – Basic Information Haemophilia A with anti factor VIII – Basic Information Pemphigoid – Treatment Methylmalonic acidaemia – Trials in Disease Pleural mesothelioma malignant – Trials in Disease Cystic fibrosis lung – Life with Disease Alport’s syndrome – Life with Disease Leukoencephalopathy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ipratropium Bromide Teplizumab Cefalexin Monohydrate Teclistamab Oric-114 Naxitamab Placebo Thiopental Sodium Eplerenone Leniolisib Phosphate 177LU-PSMA-I&T Fentanyl Citrate Rigosertib Sodium Ro7589655 Carbetocin Hydrocortisone Ph. Eur. Cipaglucosidase Alfa Betaxolol Gallium (68Ga) Heparin More therapies…

    Learn about Your Condition

    Thrombocytosis B-cell lymphoma recurrent Biliary cancer metastatic Genital infection female Hypertension Spina bifida Testicular leiomyosarcoma Erectile dysfunction Carcinoid tumour pulmonary Anorexia nervosa Hyperparathyroidism secondary Autoimmune uveitis Leukaemia Uveitis Oedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Bp 96031, Rouen, 76031, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Dupilumab Step-Down Strategy for Maintaining Remission in Adults and Adolescents with Atopic Dermatitis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Betamethasone Valerate
    • Clobetasol
    • Desonide
    France

  • Study on Atezolizumab, Bevacizumab, and Paclitaxel for Advanced Lung Cancer Patients After Immunotherapy and Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IIIB
    • Non-small cell lung cancer
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Paclitaxel
    France

  • Study on the Effectiveness of High-Dose Vitamin C for Patients with Shock After Cardiac Arrest

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Dobutamine
    • Noradrenaline Tartrate
    • Thiamine Hydrochloride
    France

  • Study on the Effectiveness and Safety of Benralizumab for Children with Severe Eosinophilic Asthma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Benralizumab
    France Germany Italy Poland Spain

  • Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

    Not recruiting

    3 1
    Investigated Diseases:
    • Heart failure with reduced ejection fraction
    Investigated Drugs:
    • Vericiguat
    Austria Czechia Denmark France Germany Greece +6

  • Study on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • 4-[3-(Cyanomethyl)-3-(3′,5′-Dimethyl-1H,1’H-[4,4′-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
    Bulgaria Denmark France Germany Italy Poland +1

  • Study on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Filgotinib
    Belgium Bulgaria Croatia Czechia Estonia France +9

  • Long-Term Follow-Up Study of Imlifidase in Highly Sensitized Kidney Transplant Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Kidney transplant rejection
    Investigated Drugs:
    • Imlifidase
    Austria Belgium Czechia France Italy The Netherlands +2

  • Study on the Effects of MK-5475 for Adults with Pulmonary Arterial Hypertension

    Not recruiting

    4 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • 3-(4-{(5S)-4-Amino-2-[6-Chloro-1-(3,3,4,4,4-Pentafluorobutyl)-1H-Indazol-3-Yl]-5-Methyl-6-Oxo6,7-Dihydro-5H-Pyrrolo[2,3-D]Pyrimidin-5-Yl}Phenyl)Propanoic Acid
    Belgium France Germany Greece Italy Poland +1

  • Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    • Milvexian
    Austria Belgium Bulgaria Croatia Czechia Denmark +16
Previous Page
1 … 43 44 45 46 47 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!